Donate Life Texas looking to increase Texas organ, eye, and tissue donors

Translate to Spanish or other 102 languages!

Donate Life Texas is launching a new campaign to encourage Texans to become organ donors in conjunction with April’s National Donate Life Month. Image for illustration purposes
Donate Life Texas is launching a new campaign to encourage Texans to become organ donors in conjunction with April’s National Donate Life Month. Image for illustration purposes

Mega Doctor News

- Advertisement -

Dallas-Fort Worth, Texas– Donate Life Texas is launching a new campaign to encourage Texans to become organ donors in conjunction with April’s National Donate Life Month.

The Glenda Dawson Donate Life Texas non-profit organization was established by the Texas legislature in 2005 and is the state’s official proponent for the organ, eye, and tissue donor registry.

“Approximately 10,000 of our fellow Texans are currently awaiting a lifesaving transplant,” said Chad G. Carroll, Executive Director of Donate Life Texas. “We are excited to launch this new campaign throughout our state and get more Texans to join our official organ donor registry in 2022 and beyond – all in the name of saving and improving lives.”

- Advertisement -

Carroll stated that most Texans consider organ donation when their driver’s license or ID card are up for renewal. In recent years, Donate Life Texas has partnered with the Texas Department of Public Safety (DPS) and the Texas Department of Motor Vehicles (DMV) to allow Texans to join the registry while applying for or renewing their driver’s license, ID card, or vehicle registration.

“We want Texans to know the facts about organ donation, make an informed decision about it for themselves, and discuss with their families and loved ones,” he said.

“Texans are known for taking care of each other and there is no more selfless act than becoming an organ, tissue, and eye donor,” said Michelle Ramirez, Community Education Specialist for DLT. “One donor has the potential to save 8 lives and improve the lives of 75 more.”

Register your decision to become an organ, eye, and tissue donor today at DonateLifeTexas.org

- Advertisement -

About Donate Life Texas

The Donate Life Texas organ donor registry started in 2005 and celebrated its thirteen millionth registration in 2021. The registry is supported by the Texas organ procurement organizations, LifeGift, Southwest Transplant Alliance and Texas Organ Sharing Alliance and the fourteen eye and tissue banks serving the state. Donate Life Texas ispart of the DonateLifeAmerica not-for-profit alliance of national organizations and local partners across the United States.

Signing up is fast and easy at DonateLifeTexas.org and provides away for individuals to make their decision to be an organ, eye and tissue donor known to the right people at the right time, automatically. It also provides legal consent for donation after death, which removes the burden of decision-making from the family during an already difficult time.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

What Persistent Fatigue Might Be Telling You

Mega Doctor News CLEVELAND CLINIC - We’ve all had those days where we’re...

AMA Unveils New Initiative to Boost Nutrition Education Nationwide

The American Medical Association (AMA) is launching a nutrition education initiative to equip physicians and medical students with practical, evidence-based knowledge and tools to help patients live healthier lives.

DHR Health to Host Headache Symposium to Address Gap in Neurological Care, March 28th

In the United States, headaches remain a common health concern, affecting approximately one in six Americans. Migraines, a type of headache, are the second leading cause of years lived with disability nationwide.

Study Finds GLP‑1 Therapy Reduces Heart and Kidney Risks for Type 1 Diabetes Patients

People with type 1 diabetes who took GLP-1 receptor agonist (GLP-1-RA) drugs for weight loss or better blood-sugar control had significantly reduced risks of major cardiovascular events and end-stage kidney disease without any increase in safety concerns, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.
- Advertisement -